How Do Technological Advances Impact Screening Intervals?
Advances in immunohistochemistry and molecular pathology have improved the accuracy and reliability of histological screenings. These technologies can help in identifying biomarkers and genetic mutations, allowing for more personalized screening intervals based on individual risk profiles. For example, individuals with a family history of certain cancers may benefit from more frequent screenings.
